Gosset Ownership
Private
Therapeutic Areas
Stage
Phase 2
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Vitti Labs General Information
Vitti Labs is conducting Phase II clinical trials for treatments involving mesenchymal stem cells and exosomes, particularly for pulmonary fibrosis secondary to COVID-19 and ARDS associated with COVID-19.
Contact Information
Website
Primary Industry
Biotech
Corporate Office
Liberty, Missouri
United States
United States
Drug Pipeline
MSC-exosome combination therapy
Phase 2Key Partnerships
Vitti Labs Funding
No funding data available
To view Vitti Labs's complete valuation and funding history, request access »